Tanezumab relieves moderate to severe pain due to Osteoarthritis (OA) of the knee: A phase 2 trial

被引：0
|
作者：
Lane, Nancy E. [1 ]
Schnitzer, Thomas J. [2 ]
Smith, Michael D. [3 ]
Brown, Mark T. [3 ]
机构：
[1] Univ Calif Davis, Med Ctr, Sacramento, CA 95817 USA
[2] Northwestern Univ, Chicago, IL 60611 USA
[3] Pfizer Inc, New London, CT USA
来源：
ARTHRITIS AND RHEUMATISM | 2008年 / 58卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S896 / S897
页数：2
相关论文
共 50 条
  • [1] Tanezumab for the Treatment of Pain from Osteoarthritis of the Knee
    Lane, Nancy E.
    Schnitzer, Thomas J.
    Birbara, Charles A.
    Mokhtarani, Masoud
    Shelton, David L.
    Smith, Mike D.
    Brown, Mark T.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (16): : 1521 - 1531
  • [2] Prevalence of knee pain, radiographic knee Osteoarthritis (OA), severe radiographic knee OA, and symptomatic knee OA: The Johnston county osteoarthritis project.
    Helmick, CG
    Renner, JB
    Luta, G
    Dragomir, AD
    Kalsbeek, W
    Abbate, L
    Hochberg, MC
    Jordan, JM
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S46 - S46
  • [3] Prevalence of knee pain, radiographic knee osteoarthritis (OA), severe radiographic knee OA, and symptomatic knee OA: The Johnston County Osteoarthritis Project.
    Helmick, C
    Renner, J
    Luta, G
    Dragomir, AD
    Kalsbeek, W
    Abbate, L
    Hochberg, MC
    Jordan, JM
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S212 - S212
  • [4] ONSET AND MAINTENANCE OF EFFICACY OF SUBCUTANEOUS TANEZUMAB IN PATIENTS WITH MODERATE TO SEVERE OSTEOARTHRITIS OF THE KNEE OR HIP
    Bessette, L.
    Schnitzer, T.
    Khan, A.
    Pixton, G.
    Viktrup, L.
    Davignon, I.
    Tive, L.
    Brown, M.
    West, C.
    OSTEOARTHRITIS AND CARTILAGE, 2019, 27 : S85 - S86
  • [5] Efficacy and tolerability of tapentadol for relief of moderate-to-severe chronic pain due to osteoarthritis of the knee
    Rauschkolb-Loeffler, C.
    Okamoto, A.
    Steup, A.
    Lange, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 507 - 507
  • [6] Efficacy and tolerability of tapentadol for relief of moderate-to-severe chronic pain due to osteoarthritis of the knee
    Rauschkolb-Loeffler, Christine
    Okamoto, Akiko
    Steup, Achim
    Lange, Claudia
    NEUROLOGY, 2008, 70 (11) : A164 - A164
  • [7] Lack of Systemic Effects from Intra-articular XT-150 for the Treatment of Moderate to Severe Pain Due to OA of the Knee: Safety Results from a Phase 2 Trial
    Kapural, Leonard
    Collins, Stephen D.
    Grigsby, Eric
    McBride, Mark
    Rieger, Jayson
    Stokes, Morgan
    Rutman, Howard
    Cicuttini, Flavia
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 612 - 614
  • [8] PAIN REDUCTION IN EITHER THE KNEE OR THE HIP WITH SUBCUTANEOUS TANEZUMAB: A POOLED ANALYSIS IN PATIENTS WITH MODERATE TO SEVERE OSTEOARTHRITIS AND A HISTORY OF INADEQUATE RESPONSE TO OTHER ANALGESICS
    Hochberg, M.
    Conaghan, P.
    Yang, R.
    Donevan, S.
    West, C.
    Verburg, K. M.
    OSTEOARTHRITIS AND CARTILAGE, 2021, 29 : S247 - S247
  • [9] Radiographic Exclusionary Findings During Screening for Three Phase III Trials of Subcutaneous Tanezumab in Patients with Moderate to Severe Hip or Knee Osteoarthritis
    Guermazi, Ali
    Roemer, Frank
    Kompel, Andrew
    Diaz, Luis
    Crema, Michel
    Brown, Mark
    Hickman, Anne
    Pixton, Glenn
    Viktrup, Lars
    Fountaine, Robert
    Burr, Aimee
    Sherlock, Sarah
    West, Christine
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [10] Osteoarthritis: Inhibitor of nerve growth factor relieves OA pain
    Price S.
    Nature Reviews Rheumatology, 2010, 6 (12) : 676 - 676
12345